MetCool ACS- Metformin Cooling Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2000 participants.
Also called NCT05305898
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 3
- Enrolled
- 2,000 participants
- Sponsor
- Military Institute od Medicine National Research Institute
- Registry
-
NCT05305898 -
2020-004962-21
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT05305898. Randomized; no masking; primary purpose other. Start 2022-02-08 (actual); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- "MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Metformin
- Lead sponsor
- Military Institute od Medicine National Research Institute
- Collaborator
- ABM Industries
Record details
- Record id
cardio:ct-nct05305898- Content hash
719171bd1568e6388b51e8c9945a09b255b531c071df3c34b96c2c7579b7e756